-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, a large number of companies have released performance announcements
.
Among them, 8 companies in the field of pharmaceutical equipment have disclosed their 2021 performance forecasts, 7 of these companies have achieved positive results, and 1 has achieved flat performance
.
From the perspective of the industry, this is the performance of the overall prosperity of the pharmaceutical equipment industry in 2021
.
It is worth noting that while various pharmaceutical machine companies are making summaries one after another, the industry is becoming more curious about the development direction of pharmaceutical machine companies and the industry in 2022
.
In this context, the author deliberately collected the development plans disclosed by some representative companies to predict the development trend of pharmaceutical machine companies and the industry in 2022
.
From the future planning of pharmaceutical machine enterprises, see the development trend of the industry! (Photo source: Pharmaceutical Network) It is understood that in December last year, Chutian Technology mentioned the key measures and growth plans for the next stage
.
Specifically, Chutian Technology plans to increase its revenue and net profit next year by no less than 20% compared with 2021
.
In the next stage, efforts will be made from both product and market aspects.
Among them, the product aspect includes increasing efforts to maintain existing advantages, focusing on the development of biomedical equipment, and establishing an innovative drug equipment development team to develop intelligent new products
.
There are three directions in the market, including vigorously promoting the import and export of high-end medical equipment; vigorously expanding overseas business
.
Establish sales and service companies in key markets, localization; export substitution,
etc.
In addition, according to the research content disclosed by Chutian Technology in July last year, in the next 3-5 years, Chutian's planned export business will also maintain an annual increase of 10%-20%.
By around 2025, the export business revenue of Chutian headquarters will account for 40%-50% of the total income will account for half of the total income
.
Not only Chutian Technology, but Tailin Biotech also publicly expressed the company's plans for various business sectors and the direction of future key development.
.
Among them, it is clearly stated that the company will always practice the mission of "serving human health and benefiting the world", focusing on the main theme of the life and health industry, and deeply cultivating the research and development and production of high-end equipment and consumables in the fields of pharmaceutical engineering, cell engineering, medical engineering, bio-environmental protection engineering, etc.
Provide system service solutions, carry out localized replacement of high-end instruments and equipment, and participate in international high-end competition
.
In addition to the above companies, a large number of domestic pharmaceutical machine companies are making new strategic layouts by recruiting talents and forming teams
.
On the whole, the author believes that increasing the international layout and developing high-end and intelligent pharmaceutical equipment has become the main development direction of most pharmaceutical equipment companies in 2022
.
In fact, in terms of internationalization, some data show that in recent years, the average growth rate of the annual export delivery value of China's pharmaceutical equipment industry has exceeded 20%
.
In addition, some domestic pharmaceutical equipment companies have also continued to increase their overseas layout, and related business income has increased significantly
.
In this context, some analysts have long said that accelerating the expansion of the international market will become a distinctive feature of the domestic pharmaceutical equipment industry
.
In the future, with the continuous improvement of domestic pharmaceutical equipment in terms of quality, technology and service, it will surely receive more and more attention in overseas markets
.
In addition, in the field of high-end equipment, with the continuous general development of the biomedical market and the continuous expansion of demand for high-end products, the domestic high-end medical equipment market has also been in a stage of rapid development in recent years
.
And compared with the foreign high-end pharmaceutical machine market, the domestic high-end medical equipment market still has huge space to be tapped
.
In the future, as domestic pharmaceutical machine companies continue to increase investment in research and development, strengthen core technology research, and policy support for the development of high-end manufacturing, it is expected that the space for import substitution in the field of high-end pharmaceutical machines will continue to expand
.
.
Among them, 8 companies in the field of pharmaceutical equipment have disclosed their 2021 performance forecasts, 7 of these companies have achieved positive results, and 1 has achieved flat performance
.
From the perspective of the industry, this is the performance of the overall prosperity of the pharmaceutical equipment industry in 2021
.
It is worth noting that while various pharmaceutical machine companies are making summaries one after another, the industry is becoming more curious about the development direction of pharmaceutical machine companies and the industry in 2022
.
In this context, the author deliberately collected the development plans disclosed by some representative companies to predict the development trend of pharmaceutical machine companies and the industry in 2022
.
From the future planning of pharmaceutical machine enterprises, see the development trend of the industry! (Photo source: Pharmaceutical Network) It is understood that in December last year, Chutian Technology mentioned the key measures and growth plans for the next stage
.
Specifically, Chutian Technology plans to increase its revenue and net profit next year by no less than 20% compared with 2021
.
In the next stage, efforts will be made from both product and market aspects.
Among them, the product aspect includes increasing efforts to maintain existing advantages, focusing on the development of biomedical equipment, and establishing an innovative drug equipment development team to develop intelligent new products
.
There are three directions in the market, including vigorously promoting the import and export of high-end medical equipment; vigorously expanding overseas business
.
Establish sales and service companies in key markets, localization; export substitution,
etc.
In addition, according to the research content disclosed by Chutian Technology in July last year, in the next 3-5 years, Chutian's planned export business will also maintain an annual increase of 10%-20%.
By around 2025, the export business revenue of Chutian headquarters will account for 40%-50% of the total income will account for half of the total income
.
Not only Chutian Technology, but Tailin Biotech also publicly expressed the company's plans for various business sectors and the direction of future key development.
.
Among them, it is clearly stated that the company will always practice the mission of "serving human health and benefiting the world", focusing on the main theme of the life and health industry, and deeply cultivating the research and development and production of high-end equipment and consumables in the fields of pharmaceutical engineering, cell engineering, medical engineering, bio-environmental protection engineering, etc.
Provide system service solutions, carry out localized replacement of high-end instruments and equipment, and participate in international high-end competition
.
In addition to the above companies, a large number of domestic pharmaceutical machine companies are making new strategic layouts by recruiting talents and forming teams
.
On the whole, the author believes that increasing the international layout and developing high-end and intelligent pharmaceutical equipment has become the main development direction of most pharmaceutical equipment companies in 2022
.
In fact, in terms of internationalization, some data show that in recent years, the average growth rate of the annual export delivery value of China's pharmaceutical equipment industry has exceeded 20%
.
In addition, some domestic pharmaceutical equipment companies have also continued to increase their overseas layout, and related business income has increased significantly
.
In this context, some analysts have long said that accelerating the expansion of the international market will become a distinctive feature of the domestic pharmaceutical equipment industry
.
In the future, with the continuous improvement of domestic pharmaceutical equipment in terms of quality, technology and service, it will surely receive more and more attention in overseas markets
.
In addition, in the field of high-end equipment, with the continuous general development of the biomedical market and the continuous expansion of demand for high-end products, the domestic high-end medical equipment market has also been in a stage of rapid development in recent years
.
And compared with the foreign high-end pharmaceutical machine market, the domestic high-end medical equipment market still has huge space to be tapped
.
In the future, as domestic pharmaceutical machine companies continue to increase investment in research and development, strengthen core technology research, and policy support for the development of high-end manufacturing, it is expected that the space for import substitution in the field of high-end pharmaceutical machines will continue to expand
.